People: GenVec Inc (GNVC.O)

GNVC.O on Consolidated Issue listed on NASDAQ Capital Market

2.20USD
19 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$2.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,845
52-wk High
$4.25
52-wk Low
$1.61

Search Stocks

Butman, Bryan 

Brief Biography

Dr. Bryan T. Butman, Ph.D., is Senior Vice President of Development of GenVec, Inc. He joined GenVec in 1999 and previously served as Director of Quality and Analytical Sciences from 1999 to 2002, Vice President of Quality from 2002 to 2005, Vice President of Vector Operations from 2005 to 2006 and Senior Vice President of Vector Operations from 2006 to 2012. Prior to joining GenVec, Dr. Butman was Executive Director of Diagnostic Product Research and Development with INTRACEL Corporation, a biotechnology company that originated from AKZO-Nobel, NV. During his 15-year career with INTRACEL, Dr. Butman developed FDA-regulated products in the areas of oncology, infectious disease, cardiovascular disease, and hematology, as well as AOAC approved products to monitor food safety. He began his product development career in 1983 as a Senior Scientist with Warner-Lambert, Co. Dr. Butman holds a Ph.D. in Biological Sciences from Wayne State University (Detroit, MI).

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
278,060 -- 97,794 395,804

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks